Krystal Biotech, Inc. (KRYS) Capital expenditures 2016–2025
Krystal Biotech, Inc. (KRYS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$12.0MFY2025 · since FY2016: $15,000 → $12.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.0M | +182.0% |
| FY2024 | $4.2M | -64.1% |
| FY2023 | $11.8M | -77.7% |
| FY2022 | $53.0M | -22.5% |
| FY2021 | $68.3M | +360.4% |
| FY2020 | $14.8M | +132.0% |
| FY2019 | $6.4M | +186.4% |
| FY2018 | $2.2M | +963.8% |
| FY2017 | $210,000 | +1300.0% |
| FY2016 | $15,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice